At Cytel, we provide the deep insights and strategic guidance needed to make confident development decisions, helping biopharma leaders navigate complex challenges across the product lifecycle.

Our Strategic Consulting team partners with organizations to shape development strategies, optimize trial design, and accelerate decision‑making. In parallel, our HEOR & RWE experts generate evidence that complements traditional randomized clinical trials, supporting submissions, expanding indications, and informing health‑economic decisions.

Visit us at booth 22 to meet Cytel consultants and HEOR & RWE specialists, and learn how our integrated services can help you drive innovation and deliver impactful outcomes.

Don’t Miss Our Sessions

Beyond the Protocol: Leveraging RWE to Inform Clinical Strategy and Strengthen Healthcare DecisionMaking

Speaker: Nathalie Horowicz Mehler, MS, MPH, PhD, Vice President, Global Head of Value & Evidence
April 14 at 9:30 AM

Panel: Accelerating Clinical Development with Adaptive Trial Approaches

Panelist: Melissa Spann, PhD, Senior Director, Strategic Consulting
April 13 at 3:00 PM